Expanded Use of Transcatheter Aortic Valve Replacement in Patients with Low Surgical Risk

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This commentary reviews the role of transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis who are at low surgical risk. Recent clinical trials show that TAVR provides outcomes comparable to surgical aortic valve replacement (SAVR) over mid-term follow-up, while offering potential benefits such as faster recovery. The authors emphasize that treatment decisions should consider patient age, anatomy, comorbidities, and long-term planning for future valve interventions.

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Faiz Saulat, Noah Blaker and Lyle Miller et al. Expanded Use of Transcatheter Aortic Valve Replacement in Patients with Low Surgical Risk. CVIA. 2026. Vol. 11(1). DOI: 10.15212/CVIA.2025.0044

CVIA Journal